Blockchain Registration Transaction Record

Calidi Biotherapeutics Appoints Eric Poma, Ph.D., as CEO to Drive Clinical Development

Calidi Biotherapeutics appoints Eric Poma, Ph.D., as CEO and Board member. Dr. Poma brings 30 years of biotech experience to lead the company's virotherapy platform growth in cancer treatment.

Calidi Biotherapeutics Appoints Eric Poma, Ph.D., as CEO to Drive Clinical Development

This news matters as the appointment of Dr. Poma as CEO of Calidi Biotherapeutics marks a significant milestone in the company's journey towards advancing its innovative virotherapy platform. With his extensive experience and leadership, the company is poised for growth and progress in the field of cancer treatment. This development underscores the importance of effective leadership in driving forward advancements in biotechnology and oncology.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xd20a1d2ab01e7ec82418f69d135e0dc70985d17fb3117c16ebf070d031281f64
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintseek_FoR-5ee9d0bc44b3b0fc6f1a32877779d327